FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,070 | -43.6% | 4,004 | -33.7% | 0.00% | – |
| Q2 2023 | $53,307 | -73.9% | 6,037 | -81.6% | 0.00% | – |
| Q1 2021 | $204,000 | -19.4% | 32,818 | -3.3% | 0.00% | – |
| Q4 2020 | $253,000 | +28.4% | 33,934 | +4.2% | 0.00% | – |
| Q3 2020 | $197,000 | -27.6% | 32,568 | 0.0% | 0.00% | – |
| Q2 2020 | $272,000 | +198.9% | 32,568 | +74.4% | 0.00% | – |
| Q1 2019 | $91,000 | -23.5% | 18,673 | 0.0% | 0.00% | – |
| Q4 2018 | $119,000 | -16.2% | 18,673 | +7.7% | 0.00% | – |
| Q3 2018 | $142,000 | -21.5% | 17,340 | 0.0% | 0.00% | – |
| Q2 2018 | $181,000 | – | 17,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |